|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US5004687A
(en)
|
1985-05-21 |
1991-04-02 |
University Of Georgia Research Foundation, Inc. |
Insect virus vector with broadened host range
|
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
|
US5273876A
(en)
|
1987-06-26 |
1993-12-28 |
Syntro Corporation |
Recombinant human cytomegalovirus containing foreign gene
|
|
CA2045129A1
(en)
|
1989-02-01 |
1990-08-02 |
Alfred I. Geller |
Herpes simplex virus type i expression vector
|
|
GB8923123D0
(en)
|
1989-10-13 |
1989-11-29 |
Connaught Lab |
A vaccine for human immunodeficiency virus
|
|
EP0549723A1
(en)
|
1990-09-21 |
1993-07-07 |
Chiron Corporation |
Packaging cells
|
|
ATE188740T1
(de)
|
1991-02-19 |
2000-01-15 |
Univ California |
Viruspartikel mit veraendertem wirtspektrum
|
|
GB9105383D0
(en)
|
1991-03-14 |
1991-05-01 |
Immunology Ltd |
An immunotherapeutic for cervical cancer
|
|
US6013638A
(en)
|
1991-10-02 |
2000-01-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
|
|
EP0552108B1
(en)
|
1992-01-17 |
1999-11-10 |
Lakowicz, Joseph R. |
Energy transfer phase-modulation fluoro-immunoassay
|
|
AU3972893A
(en)
|
1992-04-03 |
1993-11-08 |
Baylor College Of Medicine |
Gene therapy using the intestine
|
|
US6130074A
(en)
|
1992-06-01 |
2000-10-10 |
American Cyanamid Company Five Giralda Farms |
Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
|
|
SE9201984D0
(sv)
|
1992-06-29 |
1992-06-29 |
Pharmacia Biosensor Ab |
Improvement in optical assays
|
|
JP3147514B2
(ja)
|
1992-07-08 |
2001-03-19 |
住友電装株式会社 |
電線送給装置
|
|
AU6014094A
(en)
|
1992-12-02 |
1994-06-22 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
AU680508B2
(en)
|
1993-04-06 |
1997-07-31 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Gibbon ape leukemia virus-based retroviral vectors
|
|
US6133028A
(en)
|
1993-05-28 |
2000-10-17 |
Transgene S.A. |
Defective adenoviruses and corresponding complementation lines
|
|
US6120764A
(en)
|
1993-06-24 |
2000-09-19 |
Advec, Inc. |
Adenoviruses for control of gene expression
|
|
US6140087A
(en)
|
1993-06-24 |
2000-10-31 |
Advec, Inc. |
Adenovirus vectors for gene therapy
|
|
AU7353494A
(en)
|
1993-11-12 |
1995-05-29 |
Case Western Reserve University |
Episomal expression vector for human gene therapy
|
|
US5731172A
(en)
|
1994-03-09 |
1998-03-24 |
Sumitomo Pharmaceuticals Company, Ltd. |
Recombinant adenovirus and process for producing the same
|
|
US5833993A
(en)
|
1994-04-29 |
1998-11-10 |
Pharmacia & Upjohn Company |
Feline immunodeficiency virus vaccine
|
|
US5604090A
(en)
|
1994-06-06 |
1997-02-18 |
Fred Hutchinson Cancer Research Center |
Method for increasing transduction of cells by adeno-associated virus vectors
|
|
US5662897A
(en)
|
1994-07-27 |
1997-09-02 |
U. Of Ga Research Foundation |
Insect viruses, sequences, insecticidal compositions and methods of use
|
|
US5693508A
(en)
|
1994-11-08 |
1997-12-02 |
Chang; Lung-Ji |
Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
|
|
JP3770333B2
(ja)
|
1995-03-15 |
2006-04-26 |
大日本住友製薬株式会社 |
組換えdnaウイルスおよびその製造方法
|
|
GB9506782D0
(en)
|
1995-04-01 |
1995-05-24 |
British Biotech Pharm |
Retroviral vectors
|
|
CA2226575C
(en)
|
1995-07-27 |
2011-10-18 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
JPH11511326A
(ja)
|
1995-08-30 |
1999-10-05 |
ジエンザイム コーポレイション |
アデノウィルスおよびaavの精製
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6020192A
(en)
|
1996-01-18 |
2000-02-01 |
University Of Florida |
Humanized green fluorescent protein genes and methods
|
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
|
CA2247091A1
(en)
|
1996-03-05 |
1997-09-12 |
The Regents Of The University Of California |
Recombinant live feline immunodeficiency virus and proviral dna vaccines
|
|
US5952221A
(en)
|
1996-03-06 |
1999-09-14 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
|
|
US5891646A
(en)
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US6143565A
(en)
|
1997-08-22 |
2000-11-07 |
The United States Of America As Represented By The Secretary Of Agriculture |
Stable insect virus-cell expression system
|
|
US6893827B1
(en)
|
2000-02-07 |
2005-05-17 |
Applera Corporation |
Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
|
|
EP1345968A2
(en)
|
2000-12-28 |
2003-09-24 |
Altus Biologics Inc. |
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
|
JPWO2003008446A1
(ja)
|
2001-07-19 |
2004-11-11 |
三菱ウェルファーマ株式会社 |
後期糖化産物受容体のシグナル伝達に関連するポリペプチド
|
|
CN1894581B
(zh)
|
2003-07-09 |
2012-02-01 |
生命技术公司 |
检测蛋白-蛋白相互作用的方法
|
|
US7488583B2
(en)
|
2003-09-25 |
2009-02-10 |
Odyssey Thera, Inc. |
Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
|
|
ES2473587T3
(es)
|
2004-08-03 |
2014-07-07 |
Transtech Pharma, Inc. |
Proteínas de fusión de RAGE y métodos de uso
|
|
EP1869464A4
(en)
|
2005-03-17 |
2009-12-02 |
Univ Columbia |
RAGE-DIAPHANOUS INTERACTION AND CORRESPONDING COMPOSITIONS AND METHODS
|
|
JP5295785B2
(ja)
|
2006-02-20 |
2013-09-18 |
エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション |
細胞膜透過性ペプチド
|
|
MX2008011933A
(es)
|
2006-03-21 |
2008-12-18 |
Wyeth Corp |
Metodos y composiciones para antagonismo de rage.
|
|
WO2008055314A1
(en)
|
2006-11-10 |
2008-05-15 |
Dimerix Bioscience Pty Ltd |
Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
|
|
WO2008154638A2
(en)
|
2007-06-12 |
2008-12-18 |
Board Of Regents, The University Of Texas System |
Antagonists of the receptor for advanced glycation end-products (rage)
|
|
US8101373B2
(en)
|
2007-10-12 |
2012-01-24 |
Discoverx Corporation |
β-galactosidase donor fragments
|
|
WO2012109569A1
(en)
|
2011-02-11 |
2012-08-16 |
The Trustees Of Columbia University In The City Of New York |
The receptor for advanced glycation endproducts (rage) is a receptor for lysophosphatidic acid (lpa)
|
|
WO2012159164A1
(en)
|
2011-05-23 |
2012-11-29 |
Phylogica Limited |
Method of determining, identifying or isolating cell-penetrating peptides
|
|
EP2756005B1
(en)
|
2011-09-14 |
2016-03-02 |
Abeterno Technologies Limited |
Intracellular cell selection
|
|
CA3109871A1
(en)
*
|
2017-08-22 |
2019-02-28 |
Monash University |
Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage)
|